These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24414039)

  • 61. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.
    Masi G; Vasile E; Loupakis F; Cupini S; Fornaro L; Baldi G; Salvatore L; Cremolini C; Stasi I; Brunetti I; Fabbri MA; Puglisi M; Trenta P; Granetto C; Chiara S; Fioretto L; Allegrini G; Crinò L; Andreuccetti M; Falcone A
    J Natl Cancer Inst; 2011 Jan; 103(1):21-30. PubMed ID: 21123833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
    Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
    Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy.
    An X; Ding PR; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH; Li YH
    Biomarkers; 2010 May; 15(3):243-8. PubMed ID: 20121626
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.
    Chaudhury P; Hassanain M; Bouganim N; Salman A; Kavan P; Metrakos P
    HPB (Oxford); 2010 Feb; 12(1):37-42. PubMed ID: 20495643
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum C-Reactive Protein-to-Body Mass Index Ratio Predicts Overall Survival in Patients With Resected Colorectal Cancer.
    Huang L; Liu J; Huang X; Wei C; Mo X; Zhong H; Meng Y; Lai H; Zhang L; Liang D; Liu H; Tang W
    Technol Cancer Res Treat; 2021; 20():15330338211037418. PubMed ID: 34338056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
    Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
    JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study.
    Motavaf E; Sunesen KG; Stender MT; Thorlacius-Ussing O
    Int J Colorectal Dis; 2014 Nov; 29(11):1427-32. PubMed ID: 25147006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
    Li Destri G; Rubino AS; Latino R; Giannone F; Lanteri R; Scilletta B; Di Cataldo A
    Int Surg; 2015 Apr; 100(4):617-25. PubMed ID: 25875542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres.
    Baqar AR; Wilkins S; Staples M; Angus Lee CH; Oliva K; McMurrick P
    Int J Surg; 2019 Apr; 64():10-15. PubMed ID: 30822523
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
    Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
    Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
    Moreau LC; Rajan R; Thirlwell MP; Alcindor T
    Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
    Qiu MZ; Teng KY; Ruan DY; Li YH; Chen XQ; Pan ZZ; He YJ; Wan DS; Xu RH
    Ai Zheng; 2009 Jul; 28(7):743-8. PubMed ID: 19624903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?
    Carriquiry LA; Piñeyro A
    Dis Colon Rectum; 1999 Jul; 42(7):921-9. PubMed ID: 10411440
    [TBL] [Abstract][Full Text] [Related]  

  • 76. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.
    Xu Z; Wang H; Gao L; Zhang H; Wang X
    Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer.
    Bao F; Zhao LY; Balde AI; Liu H; Yan J; Li TT; Chen H; Li GX
    Colorectal Dis; 2016 Sep; 18(9):O322-9. PubMed ID: 27438774
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
    Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
    Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
    Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
    Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.